|
| |
| | | 59174 | | 17.11.2009 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.40. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 02 | Afinitor 5 mg | Tabletten | Tabletten (Everolimusum 5 mg) | L01XE10 | PI | | 03 | Afinitor 10 mg | Tabletten | Tabletten (Everolimusum 10 mg) | L01XE10 | PI | | 04 | Afinitor 2.5 mg | Tabletten | Tabletten (Everolimusum 2.5 mg) | L01XE10 | PI |
|
|
|
